Preliminary CommunicationsCONTINUOUS CONTROLLED HUMIDIFICATION OF INSPIRED AIR
References (1)
- et al.
Cited by (14)
High-flow nasal cannula oxygen therapy in acute hypoxemic respiratory failure and COVID-19-related respiratory failure
2023, Journal of Intensive MedicineCitation Excerpt :NIV through continuous positive airway pressure (CPAP) or applied with pressure support (PS) was developed <10 years later[3] and has been widely used, based on a strong level of evidence, in cardiogenic pulmonary edema and chronic obstructive pulmonary disease exacerbations; however, it is not recommended in acute hypoxemic respiratory failure.[4] HFNC was first described in 1968[5] and can be considered a non-invasive oxygen support according to its physiological effects.[6–8] Since the 2010s, its use has spread among adult patients with acute hypoxemic respiratory failure, after first being used in preterm neonates and pediatric care.
Home High-Flow Oxygen Therapy Should Be Considered in Patients With COPD and Chronic Respiratory Failure
2023, Archivos de BronconeumologiaHigh-flow nasal oxygen in acute hypoxemic respiratory failure
2022, Revue des Maladies RespiratoiresFlow Wave Interpretation of High-Flow Nasal Cannula
2022, Open Respiratory ArchivesThe role of high flow oxygen therapy in acute respiratory failure
2015, Medicina IntensivaNoninvasive Oxygenation in Patients with Acute Respiratory Failure: Current Perspectives
2022, International Journal of General Medicine
Copyright © 1968 Published by Elsevier Ltd.